The Journal of Clinical Endocrinology and Metabolism Journal Article

Clinical and Radiological Features of Atypical Adrenal Masses

July 29, 2025

A Multicenter Retrospective Study

 

Vania Balderrama-Brondani, Ruaa Al-Ward, Katja Kiseljak-Vassiliades, Lauren Fishbein, Danielle Dawes, Oksana Hamidi, Reza Pishdad, Juan Pablo Perdomo Rodriguez, Mohamad Anas Sukkari, Joseph R Grajo, Hans Kumar Ghayee, Sara Bedrose, Roland L Bassett, Amir H Hamrahian, Mouhammed Amir Habra
The Journal of Clinical Endocrinology & Metabolism, Volume 110, Issue 7, July 2025, Pages e2183–e2190
https://doi.org/10.1210/clinem/dgae781

Abstract

Context

The natural history and malignant potential of cases classified as atypical adrenal masses (AAMs) are unknown.

Objective

To describe the radiological characteristics and clinical outcomes of AAMs.

Design and Participants

A multicenter retrospective study. Patients ≥18 years old with AAMs [diameter of 10–39 mm on first imaging study and pre-contrast attenuation of >10 Hounsfield units (HU) on computed tomography] were studied. We excluded adrenal metastasis, pheochromocytoma, sarcoma, lymphoma, infiltrative lesions, and adrenal hemorrhage, as well as patients with genetic predisposition to adrenal neoplasms. Data are presented as percentages and median values with interquartile ranges (IQRs).

Results

We included 217 patients with 224 adrenal masses (61.3% women); the median age was 58 years (IQR 49–65 years). The median size was 20.5 mm (IQR 15–27 mm), with a median precontrast attenuation of 23.5 HU (IQR 17–30 HU). The median AAM growth rate was 0.3 mm/year (IQR 0–1.8 mm/year). Seventy-one masses (31.7%) underwent pathological evaluation. Adrenal adenoma (n = 38; 17%) and adrenocortical carcinoma (ACC) (n = 25; 11.2%) were the 2 most common diagnoses. For the adenomas, the growth rate was 0.3 mm/year (IQR 0–2.3 mm/year) and for ACCs, the growth rate was 12.9 mm/year (IQR 3.5–22 mm/year). The absolute contrast washout was >60% in 5 out of 7 (71.4%) ACC cases. The best growth rate cutoff for predicting malignancy was 2.68 mm/year (area under the curve 0.939; sensitivity 87.5%, specificity 88.8%).

Conclusion

AAMs carry significant malignant potential, and long-term follow-up is warranted when surgery is not pursued. Contrast washout is not reliable in predicting malignant potential of AAMs.

Read the article

 

You may also like...

Publishing Benefits

Author Resource Center

We provide our journal authors with a variety of resources for increasing the discoverability and citation of their published work. Use these tools and tips to broaden the impact of your article.
Publishing Benefits

Author Resource Center

We provide our journal authors with a variety of resources for increasing the discoverability and citation of their published work. Use these tools and tips to broaden the impact of your article.

Thematic Issue

Latest Thematic Issue

immuno-endocrinology
Read our special collections of Endocrine Society journal articles, curated by topic, Altmetric Attention Scores, and Featured Article designations.

Read our special collections of Endocrine Society journal articles, curated by topic, Altmetric Attention Scores, and Featured Article designations.

Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.